Literature DB >> 28838978

Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations.

Hartmut Grasemann1,2, Pierluigi Ciet3,4, Reshma Amin5, Nancy McDonald5, Michelle Klingel2, Harm A W M Tiddens3,4, Felix Ratjen5,2, Lars Grosse-Wortmann6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28838978     DOI： 10.1183/13993003.00244-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  10 in total

1.  Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease.

Authors:  Mark O Wielpütz; Michael Puderbach; Annette Kopp-Schneider; Mirjam Stahl; Eva Fritzsching; Olaf Sommerburg; Sebastian Ley; Migle Sumkauskaite; Jürgen Biederer; Hans-Ulrich Kauczor; Monika Eichinger; Marcus A Mall
Journal:  Am J Respir Crit Care Med       Date:  2014-04-15       Impact factor: 21.405

2.  Validating chest MRI to detect and monitor cystic fibrosis lung disease in a pediatric cohort.

Authors:  Leonie A Tepper; Pierluigi Ciet; Daan Caudri; Alexandra L Quittner; Elisabeth M W J Utens; Harm A W M Tiddens
Journal:  Pediatr Pulmonol       Date:  2015-10-05

3.  Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis.

Authors:  Sanja Stanojevic; Alexandra McDonald; Valerie Waters; Sarah MacDonald; Eric Horton; Elizabeth Tullis; Felix Ratjen
Journal:  Thorax       Date:  2016-08-18       Impact factor: 9.139

4.  Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT.

Authors:  Pierluigi Ciet; Goffredo Serra; Silvia Bertolo; Sandra Spronk; Mirco Ros; Francesco Fraioli; Serena Quattrucci; M Baroukh Assael; Carlo Catalano; Fabio Pomerri; Harm A W M Tiddens; Giovanni Morana
Journal:  Eur Radiol       Date:  2015-05-30       Impact factor: 5.315

5.  The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis.

Authors:  R Amin; P Subbarao; W Lou; A Jabar; S Balkovec; R Jensen; S Kerrigan; P Gustafsson; F Ratjen
Journal:  Eur Respir J       Date:  2010-08-06       Impact factor: 16.671

6.  Special considerations for the treatment of pulmonary exacerbations in children with cystic fibrosis.

Authors:  Valerie Waters; Sanja Stanojevic; Felix Ratjen
Journal:  Expert Rev Respir Med       Date:  2016-10-20       Impact factor: 3.772

7.  Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis.

Authors:  Mirjam Stahl; Mark O Wielpütz; Simon Y Graeber; Cornelia Joachim; Olaf Sommerburg; Hans-Ulrich Kauczor; Michael Puderbach; Monika Eichinger; Marcus A Mall
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

8.  Progression of Lung Disease in Preschool Patients with Cystic Fibrosis.

Authors:  Sanja Stanojevic; Stephanie D Davis; George Retsch-Bogart; Hailey Webster; Miriam Davis; Robin C Johnson; Renee Jensen; Maria Ester Pizarro; Mica Kane; Charles C Clem; Leah Schornick; Padmaja Subbarao; Felix A Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2017-05-01       Impact factor: 21.405

Review 9.  Lung clearance index in the assessment of airways disease.

Authors:  Alex Horsley
Journal:  Respir Med       Date:  2009-02-25       Impact factor: 3.415

10.  Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations.

Authors:  Nicole Sonneveld; Sanja Stanojevic; Reshma Amin; Paul Aurora; Jane Davies; J Stuart Elborn; Alex Horsley; Philipp Latzin; Katherine O'Neill; Paul Robinson; Emma Scrase; Hiran Selvadurai; Padmaja Subbarao; Liam Welsh; Sophie Yammine; Felix Ratjen
Journal:  Eur Respir J       Date:  2015-07-09       Impact factor: 16.671
  10 in total
  2 in total

1.  Volumetric dynamic oxygen-enhanced MRI (OE-MRI): comparison with CT Brody score and lung function in cystic fibrosis patients.

Authors:  K Martini; C M Gygax; C Benden; A R Morgan; G J M Parker; T Frauenfelder
Journal:  Eur Radiol       Date:  2018-04-13       Impact factor: 5.315

Review 2.  Current state of the art MRI for the longitudinal assessment of cystic fibrosis.

Authors:  Jason C Woods; Jim M Wild; Mark O Wielpütz; John P Clancy; Hiroto Hatabu; Hans-Ulrich Kauczor; Edwin J R van Beek; Talissa A Altes
Journal:  J Magn Reson Imaging       Date:  2019-12-17       Impact factor: 4.813
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.